Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 23
198
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Hyperprzeone A, a new benzophenone with cytotoxicity from Hypericum przewalskii Maxim

, , &
Pages 4960-4968 | Received 30 Jan 2020, Accepted 12 Apr 2020, Published online: 21 Apr 2020
 

Abstract

The phytochemical investigation on the whole plant of Hypericum przewalskii yielded a new benzophenone, hyperprzeone A (1) together with 20 known compounds (221). The structure of compound 1 was elucidated by detailed 1D and 2D NMR spectroscopic techniques as well as MS evidence. Some compounds displayed selective cytotoxic activity against six human tumour cell lines (SH-SY5Y, MDA-MB-231, SiHa, SMMC-7721, NCI-H460 and A375). Hyperprzeone A (1) showed moderate cytotoxicity against SH-SY5Y cell with the IC50 value as 25.54 μM, and further flow cytometry analysis revealed that hyperprzeone A (1) caused SH-SY5Y cell apoptosis in a dose-dependent manner by blocked the cell cycle at S phase.

Graphical Abstract

Acknowledgements

The authors thank the Center of Scientific Research of Anhui Medical University for kind help in our experiments.

Disclosure statement

The authors declare no conflict of interest.

Additional information

Funding

The work was supported by the National Natural Science Foundation of China (31670353).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.